4 results
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
Replacement - Anticoagulation ... to six months are ... anticoagulants (DOACs ... #Management #Cardiology ... #INR #Target #DOAC
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... and rivaroxaban are ... #Anticoagulation ... #Management #Hematology
Antiphospholipid Syndrome (APS)
APS is a rare autoimmune disorder characterized by recurring blood clots resulting from antibodies
to be present Treatment ... (EULAR Guidelines ... target to 3-4 • DOACs ... APS #diagnosis #management ... #guidelines
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Avoid Warfarin and DOAC ... complications are ... suggest prophylactic anticoagulation ... e.g., <50%), ESC guidelines ... #cardiology #treatment